:START_ID,:END_ID,:TYPE,evidence,evidence_location,references
e2,e1,DESTROYS,"autoimmune CD8+ T cells, which are the final mediators of beta cell destruction, circulate at similar frequencies in type 1 diabetic and healthy individuals.",19,
e1,e48,TRIGGERS,Beta cells fulfil this task by adapting ER function to these changing demands by triggering the unfolded protein response (UPR).,128,"Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56(2):234-241. https://doi.org/10.1007/s00125-012-2762-3"
e48,e49,INHIBITS,"The UPR decreases the ingress of newly synthesised proteins into the ER and increases the extrusion of misfolded proteins and the synthesis of ER chaperones, thus upgrading the folding capacity of the organelle.",130,"Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56(2):234-241. https://doi.org/10.1007/s00125-012-2762-3"
e49,e50,TRIGGERS,"If this fails to restore ER homeostasis, beta cells eventually activate the apoptotic pathway.",133,"Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56(2):234-241. https://doi.org/10.1007/s00125-012-2762-3"
e49,e51,TRIGGERS,"This dysregulated ER stress also augments local inflammation via activation of the NF-kB pathway, increasing the local release of chemokines that attract immune cells.",135,"Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56(2):234-241. https://doi.org/10.1007/s00125-012-2762-3"
e49,e52,TRIGGERS,"This dysregulated ER stress also augments local inflammation via activation of the NF-kB pathway, increasing the local release of chemokines that attract immune cells and the generation of neo-antigens.",135,"Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56(2):234-241. https://doi.org/10.1007/s00125-012-2762-3 | James EA, Pietropaolo M, Mamula MJ (2018) Immune recognition of beta-cells: neoepitopes as key players in the loss of tolerance. Diabetes 67(6):1035-1042. https://doi.org/10.2337/dbi17-0030"
e51,e58,CAUSES,"This dysregulated ER stress also augments local inflammation via activation of the NF-kB pathway, increasing the local release of chemokines that attract immune cells.",135,"Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56(2):234-241. https://doi.org/10.1007/s00125-012-2762-3"
e58,e2,ATTRACTS,increasing the local release of chemokines that attract immune cells.,135,"Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56(2):234-241. https://doi.org/10.1007/s00125-012-2762-3"
e85,e11,PREDISPOSES_TO,"Predisposing HLA Class II alleles account for most of the genetic risk, which points to the role of antigen-presenting cells (APCs) in driving disease progression via the uptake of beta cell material and the priming of CD4+ T cells.",147,
e85,e62,TRIGGERS,"Predisposing HLA Class II alleles account for most of the genetic risk, which points to the role of antigen-presenting cells (APCs) in driving disease progression via the uptake of beta cell material and the priming of CD4+ T cells.",147,
e4,e62,TRIGGERS,"Predisposing HLA Class II alleles account for most of the genetic risk, which points to the role of antigen-presenting cells (APCs) in driving disease progression via the uptake of beta cell material and the priming of CD4+ T cells.",147,
e4,e3,ACTIVATES,the role of antigen-presenting cells (APCs) in driving disease progression via the uptake of beta cell material and the priming of CD4+ T cells.,148,
e86,e51,POTENTIATES,"Other type 1 diabetes-associated gene variants can synergise with ER stress to potentiate local inflammation. These include MDA5 (also known as IFIH1), which encodes a cytoplasmic receptor for viral double-stranded RNA.",151,"Op de Beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus - why the beta cells? Nat Rev Endocrinol 12(5):263-273. https://doi.org/10.1038/nrendo.2016.30"
e18,e42,UPREGULATES,"MDA5 (also known as IFIH1), which encodes a cytoplasmic receptor for viral double-stranded RNA and is upregulated in human islets upon Coxsackievirus B (CVB) infection and potentiates chemokine release.",154,"Op de Beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus - why the beta cells? Nat Rev Endocrinol 12(5):263-273. https://doi.org/10.1038/nrendo.2016.30"
e72,e18,ACTIVATES,"MDA5 (also known as IFIH1), which encodes a cytoplasmic receptor for viral double-stranded RNA and is upregulated in human islets upon Coxsackievirus B (CVB) infection.",154,"Op de Beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus - why the beta cells? Nat Rev Endocrinol 12(5):263-273. https://doi.org/10.1038/nrendo.2016.30"
e72,e49,POTENTIATES,"environmental cues, such as islet-tropic CVB infections, which are candidate environmental triggers for type 1 diabetes, may synergise with ER stress when stochastically coming together in time and space.",159,"Op de Beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus - why the beta cells? Nat Rev Endocrinol 12(5):263-273. https://doi.org/10.1038/nrendo.2016.30"
e72,e48,ACTIVATES,recent findings suggest that CVBs use the UPR pathway IRE1alpha/XBP1s/JNK1 to foster their own replication in beta cells.,162,"Colli ML, Paula FM, Marselli L et al (2019) Coxsackievirus B tailors the unfolded protein response to favour viral amplification in pancreatic beta cells. J Innate Immun 11(4):375-390. https://doi.org/10.1159/000496034"
e72,e22,ACTIVATES,CVBs use the UPR pathway IRE1alpha/XBP1s/JNK1 to foster their own replication in beta cells.,163,"Colli ML, Paula FM, Marselli L et al (2019) Coxsackievirus B tailors the unfolded protein response to favour viral amplification in pancreatic beta cells. J Innate Immun 11(4):375-390. https://doi.org/10.1159/000496034"
e22,e23,ACTIVATES,CVBs use the UPR pathway IRE1alpha/XBP1s/JNK1 to foster their own replication in beta cells.,163,"Colli ML, Paula FM, Marselli L et al (2019) Coxsackievirus B tailors the unfolded protein response to favour viral amplification in pancreatic beta cells. J Innate Immun 11(4):375-390. https://doi.org/10.1159/000496034"
e23,e24,ACTIVATES,CVBs use the UPR pathway IRE1alpha/XBP1s/JNK1 to foster their own replication in beta cells.,163,"Colli ML, Paula FM, Marselli L et al (2019) Coxsackievirus B tailors the unfolded protein response to favour viral amplification in pancreatic beta cells. J Innate Immun 11(4):375-390. https://doi.org/10.1159/000496034"
e21,e50,INHIBITS,"This may reflect their higher resistance to ER stress-induced apoptosis, partly as a result of their higher expression of the anti-apoptotic protein Bcl2l1/BclxL.",167,"Marroqui L, Masini M, Merino B et al (2015) Pancreatic alpha cells are resistant to metabolic stress-induced apoptosis in type 2 diabetes. EBioMedicine 2(5):378-385. https://doi.org/10.1016/j.ebiom.2015.03.012"
e5,e50,INHIBITS,neighbouring alpha cells are spared by islet autoimmunity. This may reflect their higher resistance to ER stress-induced apoptosis.,166,"Marroqui L, Masini M, Merino B et al (2015) Pancreatic alpha cells are resistant to metabolic stress-induced apoptosis in type 2 diabetes. EBioMedicine 2(5):378-385. https://doi.org/10.1016/j.ebiom.2015.03.012"
e49,e57,CAUSES,the increased rate of (pro)insulin translation upon increased metabolic demands and the resulting ER stress may also lead to an increased frequency of misfolding events and accumulation of defective ribosomal products (DRiPs).,171,"Anton LC, Yewdell JW (2014) Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors. J Leukoc Biol 95(4):551-562. https://doi.org/10.1189/jlb.1113599"
e57,e53,TRIGGERS,DRiPs constitute a major source of peptides for the HLA-I processing and presentation pathway.,175,"Anton LC, Yewdell JW (2014) Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors. J Leukoc Biol 95(4):551-562. https://doi.org/10.1189/jlb.1113599"
e49,e25,UPREGULATES,ER stress upregulates the ER aminopeptidase 1 that trims the pre-proinsulin signal sequence.,182,"Thomaidou S, Kracht MJL, van der Slik A et al (2020) Beta-cell stress shapes CTL immune recognition of preproinsulin signal peptide by posttranscriptional regulation of endoplasmic reticulum aminopeptidase 1. Diabetes 69(4):670-680. https://doi.org/10.2337/db19-0984"
e25,e53,ACTIVATES,ER stress upregulates the ER aminopeptidase 1 that trims the pre-proinsulin signal sequence.,182,"Thomaidou S, Kracht MJL, van der Slik A et al (2020) Beta-cell stress shapes CTL immune recognition of preproinsulin signal peptide by posttranscriptional regulation of endoplasmic reticulum aminopeptidase 1. Diabetes 69(4):670-680. https://doi.org/10.2337/db19-0984"
e56,e52,CAUSES,"Neo-epitopes can be generated by modulation of mRNA splicing and by post-translational modifications via the upregulation of modifying enzymes, either expressed by beta cells or released by immune cells (e.g. neutrophils).",211,"James EA, Pietropaolo M, Mamula MJ (2018) Immune recognition of beta-cells: neoepitopes as key players in the loss of tolerance. Diabetes 67(6):1035-1042. https://doi.org/10.2337/dbi17-0030"
e55,e52,CAUSES,Hybrid peptides generated by the fusion of non-contiguous sequences from the same proteins or from distinct partners have also been described. This so-called transpeptidation process was originally reported to generate CD8+ T cell epitopes through the proteasome pathway.,212,"Delong T, Wiles TA, Baker RL et al (2016) Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351(6274):711-714. https://doi.org/10.1126/science.aad2791 | Vigneron N, Stroobant V, Chapiro J et al (2004) An antigenic peptide produced by peptide splicing in the proteasome. Science 304(5670):587-590. https://doi.org/10.1126/science.1095522 | Wan X, Vomund AN, Peterson OJ, Chervonsky AV, Lichti CF, Unanue ER (2020) The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides. Nat Immunol 21(4):455-463. https://doi.org/10.1038/s41590-020-0623-7"
e54,e53,TRIGGERS,"A similar shunting towards the HLA-I pathway may take place under inflammatory conditions, in which glucose-stimulated insulin secretion is downregulated and unused granules are degraded through crinophagy.",202,
e1,e41,RELEASES,"chemokines (e.g. CCL2 and CXCL10) released by beta cells, which further attract and activate immune cells.",252,"Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5(4):219-226. https://doi.org/10.1038/nrendo.2009.21"
e1,e42,RELEASES,"chemokines (e.g. CCL2 and CXCL10) released by beta cells, which further attract and activate immune cells.",252,"Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5(4):219-226. https://doi.org/10.1038/nrendo.2009.21"
e41,e2,ATTRACTS,"chemokines (e.g. CCL2 and CXCL10) released by beta cells, which further attract and activate immune cells.",252,"Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5(4):219-226. https://doi.org/10.1038/nrendo.2009.21"
e42,e2,ATTRACTS,"chemokines (e.g. CCL2 and CXCL10) released by beta cells, which further attract and activate immune cells.",252,"Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5(4):219-226. https://doi.org/10.1038/nrendo.2009.21"
e59,e6,ATTRACTS,beta cell death releases self-DNA and recruits neutrophils to the pancreas.,257,"Diana J, Simoni Y, Furio L et al (2013) Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 19(1):65-73. https://doi.org/10.1038/nm.3042"
e6,e7,ACTIVATES,"The concerted action of self-DNA, anti-DNA antibodies and DNA-binding anti-microbial peptides secreted by neutrophils activates plasmacytoid dendritic cells.",259,"Diana J, Simoni Y, Furio L et al (2013) Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 19(1):65-73. https://doi.org/10.1038/nm.3042"
e7,e37,RELEASES,"activates plasmacytoid dendritic cells, leading to IFN-alpha production and amplification of the autoimmune response through T cell recruitment.",261,"Diana J, Simoni Y, Furio L et al (2013) Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 19(1):65-73. https://doi.org/10.1038/nm.3042"
e37,e12,TRIGGERS,IFN-alpha plays a key role in early insulitis by linking the activation of innate and adaptive immunity.,263,
e37,e2,ATTRACTS,amplification of the autoimmune response through T cell recruitment.,,"Diana J, Simoni Y, Furio L et al (2013) Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 19(1):65-73. https://doi.org/10.1038/nm.3042"
e37,e33,UPREGULATES,inflammatory cytokines upregulate HLA-I expression on beta cells and increase the number of peptides presented for scanning and recognition by CD8+ T cells.,269,"Gonzalez-Duque S, Azoury ME, Colli ML et al (2018) Conventional and neo-antigenic peptides presented by beta cells are targeted by circulating naive CD8+ T cells in type 1 diabetic and healthy donors. Cell Metab 28(6):946-960. https://doi.org/10.1016/j.cmet.2018.07.007"
e38,e33,UPREGULATES,inflammatory cytokines upregulate HLA-I expression on beta cells and increase the number of peptides presented for scanning and recognition by CD8+ T cells.,269,"Gonzalez-Duque S, Azoury ME, Colli ML et al (2018) Conventional and neo-antigenic peptides presented by beta cells are targeted by circulating naive CD8+ T cells in type 1 diabetic and healthy donors. Cell Metab 28(6):946-960. https://doi.org/10.1016/j.cmet.2018.07.007"
e39,e33,UPREGULATES,inflammatory cytokines upregulate HLA-I expression on beta cells and increase the number of peptides presented for scanning and recognition by CD8+ T cells.,269,"Gonzalez-Duque S, Azoury ME, Colli ML et al (2018) Conventional and neo-antigenic peptides presented by beta cells are targeted by circulating naive CD8+ T cells in type 1 diabetic and healthy donors. Cell Metab 28(6):946-960. https://doi.org/10.1016/j.cmet.2018.07.007"
e77,e13,BIOMARKER_FOR,an IFN-alpha signature precedes the appearance of autoantibodies in the peripheral blood and may be associated with neutrophils.,272,"Kallionpaa H, Elo LL, Laajala E et al (2014) Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes 63(7):2402-2414. https://doi.org/10.2337/db13-1775 | Ferreira RC, Guo H, Coulson RM et al (2014) A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes 63(7):2538-2550. https://doi.org/10.2337/db13-1777"
e37,e49,CAUSES,"IFN-alpha induces greater ER stress in beta cells compared with IFN-gamma, which translates into apoptosis only upon concomitant exposure to IL-1beta.",277,"Marroqui L, Dos Santos RS, Op de Beeck A et al (2017) Interferon-alpha mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes. Diabetologia 60(4):656-667. https://doi.org/10.1007/s00125-016-4201-3"
e37,e35,UPREGULATES,"IFN-alpha and IFN-gamma upregulate beta cell expression not only of chemokines and HLA-I, but also of programmed cell death ligand 1 (PD-L1).",282,"Marroqui L, Dos Santos RS, Op de Beeck A et al (2017) Interferon-alpha mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes. Diabetologia 60(4):656-667. https://doi.org/10.1007/s00125-016-4201-3"
e38,e35,UPREGULATES,"IFN-alpha and IFN-gamma upregulate beta cell expression not only of chemokines and HLA-I, but also of programmed cell death ligand 1 (PD-L1).",282,"Osum KC, Burrack AL, Martinov T et al (2018) Interferon-gamma drives programmed death-ligand 1 expression on islet beta cells to limit T cell function during autoimmune diabetes. Sci Rep 8(1):8295. https://doi.org/10.1038/s41598-018-26471-9 | Colli ML, Hill JLE, Marroqui L et al (2018) PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-alpha and-gamma via IRF1 induction. EBioMedicine 36:367-375. https://doi.org/10.1016/j.ebiom.2018.09.040"
e35,e2,INHIBITS,"PD-L1, which is hyper-expressed in the beta cells of type 1 diabetic patients, possibly reflecting an active yet insufficient peripheral tolerance mechanism through programmed cell death protein 1 (PD-1) binding and T cell inhibition.",286,"Osum KC, Burrack AL, Martinov T et al (2018) Interferon-gamma drives programmed death-ligand 1 expression on islet beta cells to limit T cell function during autoimmune diabetes. Sci Rep 8(1):8295. https://doi.org/10.1038/s41598-018-26471-9 | Colli ML, Hill JLE, Marroqui L et al (2018) PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-alpha and-gamma via IRF1 induction. EBioMedicine 36:367-375. https://doi.org/10.1016/j.ebiom.2018.09.040"
e36,e2,INHIBITS,peripheral tolerance mechanism through programmed cell death protein 1 (PD-1) binding and T cell inhibition.,287,"Osum KC, Burrack AL, Martinov T et al (2018) Interferon-gamma drives programmed death-ligand 1 expression on islet beta cells to limit T cell function during autoimmune diabetes. Sci Rep 8(1):8295. https://doi.org/10.1038/s41598-018-26471-9 | Colli ML, Hill JLE, Marroqui L et al (2018) PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-alpha and-gamma via IRF1 induction. EBioMedicine 36:367-375. https://doi.org/10.1016/j.ebiom.2018.09.040 | Ehlers MR (2018) Who let the dogs out? The ever-present threat of autoreactive T cells. Sci Immunol 3(20):eaar6602. https://doi.org/10.1126/sciimmunol.aar6602"
e81,e36,INHIBITS,Therapeutic anti-PD-1/PD-L1 antibodies are increasingly used for treating cancers that evade immune surveillance by overexpressing PD-L1.,289,"Stamatouli AM, Quandt Z, Perdigoto AL et al (2018) Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors. Diabetes 67(8):1471-1480. https://doi.org/10.2337/dbi18-0002"
e82,e35,INHIBITS,Therapeutic anti-PD-1/PD-L1 antibodies are increasingly used for treating cancers that evade immune surveillance by overexpressing PD-L1.,289,"Stamatouli AM, Quandt Z, Perdigoto AL et al (2018) Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors. Diabetes 67(8):1471-1480. https://doi.org/10.2337/dbi18-0002"
e81,e11,TRIGGERS,"8-10% of treated patients develop endocrine autoimmune disorders, e.g. hypophysitis, thyroiditis, adrenal disease and, in 0.4-0.9% of patients, a fulminant form of diabetes.",292,"Stamatouli AM, Quandt Z, Perdigoto AL et al (2018) Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors. Diabetes 67(8):1471-1480. https://doi.org/10.2337/dbi18-0002"
e81,e14,TRIGGERS,"8-10% of treated patients develop endocrine autoimmune disorders, e.g. hypophysitis, thyroiditis, adrenal disease.",292,"Stamatouli AM, Quandt Z, Perdigoto AL et al (2018) Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors. Diabetes 67(8):1471-1480. https://doi.org/10.2337/dbi18-0002"
e81,e15,TRIGGERS,"8-10% of treated patients develop endocrine autoimmune disorders, e.g. hypophysitis, thyroiditis, adrenal disease.",292,"Stamatouli AM, Quandt Z, Perdigoto AL et al (2018) Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors. Diabetes 67(8):1471-1480. https://doi.org/10.2337/dbi18-0002"
e81,e16,TRIGGERS,"8-10% of treated patients develop endocrine autoimmune disorders, e.g. hypophysitis, thyroiditis, adrenal disease.",292,"Stamatouli AM, Quandt Z, Perdigoto AL et al (2018) Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors. Diabetes 67(8):1471-1480. https://doi.org/10.2337/dbi18-0002"
e8,e64,LOCATED_IN,"In islets from non-diabetic donors, the group of Cilio found that most (80%) immune cells are CD3+ T cells, 80% of which had a central/effector memory phenotype expressing the CD69 and CD103 markers of tissue residency.",311,"Radenkovic M, Uvebrant K, Skog O et al (2017) Characterization of resident lymphocytes in human pancreatic islets. Clin Exp Immunol 187(3):418-427. https://doi.org/10.1111/cei.12892"
e73,e11,BIOMARKER_FOR,following residual insulin secretion by measuring C-peptide release after a glucose challenge.,448,"Sims EK, Evans-Molina C, Tersey SA, Eizirik DL, Mirmira RG (2018) Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61(11):2259-2265. https://doi.org/10.1007/s00125-018-4712-1"
e27,e11,BIOMARKER_FOR,circulating proinsulin is now widely accepted as one such biomarker.,450,"Sims EK, Evans-Molina C, Tersey SA, Eizirik DL, Mirmira RG (2018) Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61(11):2259-2265. https://doi.org/10.1007/s00125-018-4712-1"
e43,e11,BIOMARKER_FOR,"Other products released by beta cells (e.g. GAD65, IAPP, microRNAs) are under scrutiny.",451,"Sims EK, Evans-Molina C, Tersey SA, Eizirik DL, Mirmira RG (2018) Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61(11):2259-2265. https://doi.org/10.1007/s00125-018-4712-1"
e74,e11,BIOMARKER_FOR,"Other products released by beta cells (e.g. GAD65, IAPP, microRNAs) are under scrutiny.",451,"Sims EK, Evans-Molina C, Tersey SA, Eizirik DL, Mirmira RG (2018) Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61(11):2259-2265. https://doi.org/10.1007/s00125-018-4712-1"
e75,e11,BIOMARKER_FOR,circulating biomarkers of beta cell stress may be complementary to immune biomarkers such as autoantibodies.,446,"Sims EK, Evans-Molina C, Tersey SA, Eizirik DL, Mirmira RG (2018) Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61(11):2259-2265. https://doi.org/10.1007/s00125-018-4712-1"
e76,e11,BIOMARKER_FOR,the detection of DNA species carrying beta cell-specific methylation marks and released upon cell death.,453,
e78,e49,TREATS,"ursodeoxycholic acid, a bile acid used to reduce cholestasis which can also function as a chaperone to quell ER stress.",481,"Engin F, Yermalovich A, Nguyen T et al (2013) Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes. Sci Transl Med 5(211):211ra156. https://doi.org/10.1126/scitranslmed.3006534"
e79,e45,INHIBITS,"verapamil, an anti-hypertensive, anti-arrhythmic drug that inhibits thioredoxin-interacting protein (TXNIP), a pro-oxidative factor that activates the inflammasome.",483,"Ovalle F, Grimes T, Xu G et al (2018) Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat Med 24(8):1108-1112. https://doi.org/10.1038/s41591-018-0089-4"
e45,e51,ACTIVATES,"thioredoxin-interacting protein (TXNIP), a pro-oxidative factor that activates the inflammasome.",483,"Ovalle F, Grimes T, Xu G et al (2018) Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat Med 24(8):1108-1112. https://doi.org/10.1038/s41591-018-0089-4"
e80,e11,TREATS,Glucagon-like peptide 1 (GLP-1) agonists have also been shown to have beneficial effects on beta cells in rodent models.,485,"Kielgast U, Holst JJ, Madsbad S (2011) Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual beta-cell function. Diabetes 60(5):1599-1607. https://doi.org/10.2337/db10-1790"
e83,e37,INHIBITS,"Other agents under study target IFN-alpha signalling pathways in beta cells, e.g. JAK/TYK2/STAT inhibitors.",489,"Coomans de Brachene A, Dos Santos RS, Marroqui L et al (2018) IFN-alpha induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells. Diabetologia 61(3):636-640. https://doi.org/10.1007/s00125-017-4536-4 | Colli ML, Hill JLE, Marroqui L et al (2018) PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-alpha and-gamma via IRF1 induction. EBioMedicine 36:367-375. https://doi.org/10.1016/j.ebiom.2018.09.040 | Trivedi PM, Graham KL, Scott NA et al (2017) Repurposed JAK1/JAK2 inhibitor reverses established autoimmune insulitis in NOD mice. Diabetes 66(6):1650-1660. https://doi.org/10.2337/db16-1250"
e84,e11,TRIGGERS,bone marrow transplantation from a HLA-identical type 1 diabetic sibling into a non-diabetic recipient led to the development of type 1 diabetes.,512,"Lampeter EF, Homberg M, Quabeck K et al (1993) Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341(8855):1243-1244. https://doi.org/10.1016/0140-6736(93)91148-f"
e1,e27,RELEASES,"stressed beta cells also release high amounts of proinsulin, which has a longer half-life than insulin and binds poorly to the insulin receptor.",350,
e86,e11,PREDISPOSES_TO,"Gene variants that may predispose individuals to this vulnerability have been identified, e.g. MDA5, TYK2, PTPN2.",24,
e87,e11,PREDISPOSES_TO,"Gene variants that may predispose individuals to this vulnerability have been identified, e.g. MDA5, TYK2, PTPN2.",24,
e88,e11,PREDISPOSES_TO,"Gene variants that may predispose individuals to this vulnerability have been identified, e.g. MDA5, TYK2, PTPN2.",24,
e61,e49,CAUSES,"impaired proinsulin processing that affects stressed beta cells, which may promote their immunogenicity by further favouring ER stress and HLA Class I (HLA-I) presentation of proinsulin peptides.",87,"Rodriguez-Calvo T, Zapardiel-Gonzalo J, Amirian N et al (2017) Increase in pancreatic proinsulin and preservation of beta-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. Diabetes 66(5):1334-1345. https://doi.org/10.2337/db16-1343 | Wasserfall C, Nick HS, Campbell-Thompson M et al (2017) Persistence of pancreatic insulin mRNA expression and proinsulin protein in type 1 diabetes pancreata. Cell Metab 26(3):568-575. https://doi.org/10.1016/j.cmet.2017.08.013"
e29,e53,ASSOCIATED_WITH,These proteins are major contributors to the HLA-I peptidome presented by beta cells and recognised by T cells.,186,"Gonzalez-Duque S, Azoury ME, Colli ML et al (2018) Conventional and neo-antigenic peptides presented by beta cells are targeted by circulating naive CD8+ T cells in type 1 diabetic and healthy donors. Cell Metab 28(6):946-960. https://doi.org/10.1016/j.cmet.2018.07.007"
e30,e53,ASSOCIATED_WITH,These proteins are major contributors to the HLA-I peptidome presented by beta cells and recognised by T cells.,186,"Gonzalez-Duque S, Azoury ME, Colli ML et al (2018) Conventional and neo-antigenic peptides presented by beta cells are targeted by circulating naive CD8+ T cells in type 1 diabetic and healthy donors. Cell Metab 28(6):946-960. https://doi.org/10.1016/j.cmet.2018.07.007"
e31,e53,ASSOCIATED_WITH,These proteins are major contributors to the HLA-I peptidome presented by beta cells and recognised by T cells.,186,"Gonzalez-Duque S, Azoury ME, Colli ML et al (2018) Conventional and neo-antigenic peptides presented by beta cells are targeted by circulating naive CD8+ T cells in type 1 diabetic and healthy donors. Cell Metab 28(6):946-960. https://doi.org/10.1016/j.cmet.2018.07.007"
e32,e53,ASSOCIATED_WITH,These proteins are major contributors to the HLA-I peptidome presented by beta cells and recognised by T cells.,186,"Gonzalez-Duque S, Azoury ME, Colli ML et al (2018) Conventional and neo-antigenic peptides presented by beta cells are targeted by circulating naive CD8+ T cells in type 1 diabetic and healthy donors. Cell Metab 28(6):946-960. https://doi.org/10.1016/j.cmet.2018.07.007"
e64,e65,LOCATED_IN,The encounter between immune cells and beta cells is favoured by the rich vascularisation of islets.,227,
e67,e65,LOCATED_IN,"activated immune cells, likely primed in pancreatic lymph nodes (pLNs), can readily cross the vascular endothelium.",234,
e9,e13,INHIBITS,"near absence of regulatory T cells compared with other organs, irrespective of disease status. This may represent another feature making islets more vulnerable to autoimmunity.",322,"Radenkovic M, Uvebrant K, Skog O et al (2017) Characterization of resident lymphocytes in human pancreatic islets. Clin Exp Immunol 187(3):418-427. https://doi.org/10.1111/cei.12892"
e37,e17,ASSOCIATED_WITH,"IFN-alpha plays a key role in early insulitis by linking the activation of innate and adaptive immunity, as documented in other autoimmune diseases such as lupus.",263,
e45,e63,TRIGGERS,"thioredoxin-interacting protein (TXNIP), a pro-oxidative factor that activates the inflammasome.",483,"Ovalle F, Grimes T, Xu G et al (2018) Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat Med 24(8):1108-1112. https://doi.org/10.1038/s41591-018-0089-4"
e70,e64,LOCATED_IN,"secretory granules also contain antigenic insulin peptides, which, together with intact granule proteins, may provide another source of T cell sensitisation at a distance.",355,"Wan X, Zinselmeyer BH, Zakharov PN et al (2018) Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides. Nature 560(7716):107-111. https://doi.org/10.1038/s41586-018-0341-6"
e1,e26,EXPRESSES,"Following nutrient stimulation, (pro)insulin synthesis by beta cells is increased by more than ten-fold, representing nearly 50% of total beta cell protein production.",124,
e28,e53,ASSOCIATED_WITH,"Several other epitopes originate from the pre-proinsulin signal sequence, which becomes an abundant by-product of proinsulin biosynthesis upon its translocation into the ER.",180,"Kronenberg-Versteeg D, Eichmann M, Russell MA et al (2018) Molecular pathways for immune recognition of preproinsulin signal peptide in type 1 diabetes. Diabetes 67(4):687-696. https://doi.org/10.2337/db17-0021"
e4,e34,EXPRESSES,APCs in driving disease progression via the uptake of beta cell material and the priming of CD4+ T cells.,149,
e10,e64,LOCATED_IN,even for naive and non-islet-reactive T cells.,237,"Magnuson AM, Thurber GM, Kohler RH, Weissleder R, Mathis D, Benoist C (2015) Population dynamics of islet-infiltrating cells in autoimmune diabetes. Proc Natl Acad Sci U S A 112(5):1511-1516. https://doi.org/10.1073/pnas.1423769112 | Christoffersson G, Chodaczek G, Ratliff SS, Coppieters K, von Herrath MG (2018) Suppression of diabetes by accumulation of non-islet-specific CD8+ effector T cells in pancreatic islets. Sci Immunol 3(21):eaam6533. https://doi.org/10.1126/sciimmunol.aam6533"
e46,e11,ASSOCIATED_WITH,"Glucagon-like peptide 1 (GLP-1) agonists have also been shown to have beneficial effects on beta cells in rodent models, but whether the benefits observed in some trials on type 1 diabetic patients reflect an improvement in residual insulin secretion is currently debated.",485,"Kielgast U, Holst JJ, Madsbad S (2011) Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual beta-cell function. Diabetes 60(5):1599-1607. https://doi.org/10.2337/db10-1790"
e44,e53,ASSOCIATED_WITH,"exosomes carrying antigens such as proinsulin, GAD65 and islet antigen 2 (IA-2), which are endocytosed more efficiently than soluble proteins/peptides and may further feed distant APCs.",420,"Cianciaruso C, Phelps EA, Pasquier M et al (2017) Primary human and rat beta-cells release the intracellular autoantigens GAD65, IA-2, and proinsulin in exosomes together with cytokine-induced enhancers of immunity. Diabetes 66(2):460-473. https://doi.org/10.2337/db16-0671"
e69,e64,LOCATED_IN,"transpeptidation process may also generate CD4+ T cell epitopes and take place in the insulin granules and, more likely, in the crinosomes (formed from the fusion of granules and lysosomes).",215,"Wan X, Vomund AN, Peterson OJ, Chervonsky AV, Lichti CF, Unanue ER (2020) The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides. Nat Immunol 21(4):455-463. https://doi.org/10.1038/s41590-020-0623-7"
e72,e11,TRIGGERS,"islet-tropic CVB infections, which are candidate environmental triggers for type 1 diabetes.",159,"Op de Beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus - why the beta cells? Nat Rev Endocrinol 12(5):263-273. https://doi.org/10.1038/nrendo.2016.30 | Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5(4):219-226. https://doi.org/10.1038/nrendo.2009.21"
e51,e52,TRIGGERS,Islet inflammation may also lead to the increased generation of neoepitopes that are not encoded in the genome.,206,"James EA, Pietropaolo M, Mamula MJ (2018) Immune recognition of beta-cells: neoepitopes as key players in the loss of tolerance. Diabetes 67(6):1035-1042. https://doi.org/10.2337/dbi17-0030"
e38,e51,TRIGGERS,"followed by an amplification stage triggered by other cytokines, e.g. IFN-gamma, TNF-alpha and IL-1beta.",275,
e39,e51,TRIGGERS,"followed by an amplification stage triggered by other cytokines, e.g. IFN-gamma, TNF-alpha and IL-1beta.",275,
e40,e51,TRIGGERS,"followed by an amplification stage triggered by other cytokines, e.g. IFN-gamma, TNF-alpha and IL-1beta.",275,
e27,e53,ASSOCIATED_WITH,"impaired proinsulin processing that affects stressed beta cells, which may promote their immunogenicity by further favouring ER stress and HLA Class I (HLA-I) presentation of proinsulin peptides.",87,"Rodriguez-Calvo T, Zapardiel-Gonzalo J, Amirian N et al (2017) Increase in pancreatic proinsulin and preservation of beta-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. Diabetes 66(5):1334-1345. https://doi.org/10.2337/db16-1343 | Wasserfall C, Nick HS, Campbell-Thompson M et al (2017) Persistence of pancreatic insulin mRNA expression and proinsulin protein in type 1 diabetes pancreata. Cell Metab 26(3):568-575. https://doi.org/10.1016/j.cmet.2017.08.013"
e74,e13,ASSOCIATED_WITH,"Beta cell-derived microRNAs released into the bloodstream, either in soluble form or associated with exosomes, may exert additional immunomodulatory effects.",423,"Ventriglia G, Mancarella F, Sebastiani G et al (2020) miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes. Diabetologia 63(1):124-136. https://doi.org/10.1007/s00125-019-05026-1"
e89,e11,BIOMARKER_FOR,"Other products released by beta cells (e.g. GAD65, IAPP, microRNAs) are under scrutiny.",451,"Sims EK, Evans-Molina C, Tersey SA, Eizirik DL, Mirmira RG (2018) Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61(11):2259-2265. https://doi.org/10.1007/s00125-018-4712-1"
e19,e51,ASSOCIATED_WITH,"TYK2 and PTPN2, which encode key interferon signalling transducers in beta cells.",157,"Op de Beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus - why the beta cells? Nat Rev Endocrinol 12(5):263-273. https://doi.org/10.1038/nrendo.2016.30"
e20,e51,ASSOCIATED_WITH,"TYK2 and PTPN2, which encode key interferon signalling transducers in beta cells.",157,"Op de Beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus - why the beta cells? Nat Rev Endocrinol 12(5):263-273. https://doi.org/10.1038/nrendo.2016.30"
